The Zhitong Finance App notes that medical device companies will experience another sluggish earnings season, then enter 2027 with the strongest growth prospects in more than two years — the industry has experienced a difficult period full of policy uncertainty, cyber attacks, and product recalls.

The Zhitong Finance App notes that medical device companies will experience another sluggish earnings season, then enter 2027 with the strongest growth prospects in more than two years — the industry has experienced a difficult period full of policy uncertainty, cyber attacks, and product recalls.